搜索临床试验以:Expanded Access
总计3654个结果
-
Organicell Regenerative Medicine可用的新冠肺炎 | 急性呼吸窘迫综合征 | 冠状病毒感染 | SARS(严重急性呼吸系统综合症)
-
DBV TechnologiesTodd D. Green MD, DBV Technologies可用的
-
APR Applied Pharma Research s.a.Cavendish Impact Foundation; Clinigen, Inc.; Nephron Pharmaceuticals, Inc.不再可用
-
Intergroupe Francophone de Cancerologie ThoraciqueNovartis完全的
-
Hope Biosciences Stem Cell Research FoundationHope Biosciences不再可用
-
Hope Biosciences Stem Cell Research FoundationHope Biosciences不再可用
-
Joanne Kurtzberg, MDDuke University; Miltenyi Biotec, Inc.可用的
-
Millennium Pharmaceuticals, Inc.批准上市
-
Hope Biosciences Stem Cell Research FoundationHope Biosciences不再可用
-
Hope Biosciences Stem Cell Research FoundationHope Biosciences不再可用
-
ContraFect不再可用
-
Rhythm Pharmaceuticals, Inc.批准上市肥胖 | Bardet-Biedl 综合症 (BBS)
-
Hope Biosciences Stem Cell Research FoundationHope Biosciences不再可用
-
Hope Biosciences Stem Cell Research FoundationHope Biosciences不再可用
-
Hope Biosciences Stem Cell Research FoundationHope Biosciences不再可用
-
Clinton Health Access Initiative Inc.Bill and Melinda Gates Foundation; Cameroon Expanded Program on Immunization完全的
-
Genentech, Inc.批准上市
-
AbbVie不再可用高级别浆液性卵巢癌 | 具有记录在案的 BRCA、BARD 或 PALB 或其他科学上合理的可接受的 DNA 突变或异常的实体瘤 | 三阴性乳腺癌 (TNBC) | 需要 Veliparib 混悬剂的患者